Fidelity Accumulates 15% Stake In XENOPORT (XNPT)
Tweet
Share
E-mailGet Alerts XNPT Hot Sheet
Join SI Premium – FREE
In a 13G filing on XENOPORT (Nasdaq: XNPT), FMR LLC, the parent of mutual fund giant Fidelity, disclosed a 14.99%, or 5,300,029 share, stake in the company.
The firm held just 564,200 shares at the end of Q4.
XenoPort, Inc., a biopharmaceutical company, focuses on developing internally discovered product candidates that utilize the bodys natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs.
The firm held just 564,200 shares at the end of Q4.
XenoPort, Inc., a biopharmaceutical company, focuses on developing internally discovered product candidates that utilize the bodys natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs.
Create E-mail Alert Related Categories
13GsRelated Entities
Fidelity Investments, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
